Product Code: ETC6189482 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The psittacosis treatment market in Australia remains modest due to the low incidence of this zoonotic disease, primarily transmitted from birds. Doxycycline remains the first-line treatment, with rapid diagnosis and early antibiotic intervention proving effective. Increased surveillance of avian species and improved awareness among veterinarians and general practitioners may contribute to timely management and containment, although broader public health campaigns are limited.
Australia psittacosis treatment market is relatively niche but important due to its zoonotic nature and the country`s large population of bird owners and avian workers. The increasing implementation of occupational health standards in poultry farms and pet bird environments is improving detection and treatment rates. The use of tetracycline antibiotics remains the standard, but there`s an emerging focus on rapid diagnostic kits to facilitate early intervention. Public health surveillance and awareness campaigns have also positively influenced early treatment initiation.
The Australia Psittacosis Treatment Market faces challenges related to the rare nature of the disease and its association with the handling of infected birds. This limited incidence of psittacosis means there is little market demand for treatments, which hinders the development of new therapies. Additionally, there are challenges in raising awareness among healthcare providers about the need to test for psittacosis, which can delay diagnosis and treatment. The market is further impacted by the availability of generic antibiotics, which are often sufficient for treating the condition, limiting the potential for more specialized treatments.
As zoonotic diseases gain attention due to their pandemic potential, the psittacosis treatment market in Australiawhere pet birds and poultry farming are commonpresents a growing opportunity. Investment in rapid diagnostics, preventive vaccines, and antibiotic R&D can help address this niche infectious disease. There is also scope for public-private partnerships focused on zoonosis control.
Psittacosis is a notifiable zoonotic disease in Australia, regulated under national biosecurity and communicable disease surveillance frameworks. The Department of Health and Aged Care, in coordination with state health departments, enforces disease control, antibiotic usage guidelines, and animal handling regulations to prevent outbreaks.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Psittacosis Treatment Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Psittacosis Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Psittacosis Treatment Market - Industry Life Cycle |
3.4 Australia Psittacosis Treatment Market - Porter's Five Forces |
3.5 Australia Psittacosis Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Psittacosis Treatment Market Revenues & Volume Share, By Antibiotic Type, 2021 & 2031F |
3.7 Australia Psittacosis Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 Australia Psittacosis Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Australia Psittacosis Treatment Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
3.10 Australia Psittacosis Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Psittacosis Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of psittacosis cases in Australia |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of psittacosis |
4.2.3 Advancements in medical research leading to more effective treatment options |
4.3 Market Restraints |
4.3.1 Limited availability of specialized healthcare facilities for psittacosis treatment |
4.3.2 High cost of treatment and medications for psittacosis |
4.3.3 Lack of standardized treatment guidelines for psittacosis in Australia |
5 Australia Psittacosis Treatment Market Trends |
6 Australia Psittacosis Treatment Market, By Types |
6.1 Australia Psittacosis Treatment Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Psittacosis Treatment Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Psittacosis Treatment Market Revenues & Volume, By Chlamydia Psittaci, 2021- 2031F |
6.1.4 Australia Psittacosis Treatment Market Revenues & Volume, By Chickens, 2021- 2031F |
6.1.5 Australia Psittacosis Treatment Market Revenues & Volume, By Turkeys, 2021- 2031F |
6.1.6 Australia Psittacosis Treatment Market Revenues & Volume, By Pigeons, 2021- 2031F |
6.1.7 Australia Psittacosis Treatment Market Revenues & Volume, By Parakeets, 2021- 2031F |
6.2 Australia Psittacosis Treatment Market, By Antibiotic Type |
6.2.1 Overview and Analysis |
6.2.2 Australia Psittacosis Treatment Market Revenues & Volume, By Tetracycline, 2021- 2031F |
6.2.3 Australia Psittacosis Treatment Market Revenues & Volume, By Chloramphenicol, 2021- 2031F |
6.2.4 Australia Psittacosis Treatment Market Revenues & Volume, By Doxycycline, 2021- 2031F |
6.3 Australia Psittacosis Treatment Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 Australia Psittacosis Treatment Market Revenues & Volume, By Medication, 2021- 2031F |
6.3.3 Australia Psittacosis Treatment Market Revenues & Volume, By Antibiotic Therapy, 2021- 2031F |
6.3.4 Australia Psittacosis Treatment Market Revenues & Volume, By Supportive Care, 2021- 2031F |
6.4 Australia Psittacosis Treatment Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Australia Psittacosis Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Australia Psittacosis Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Australia Psittacosis Treatment Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.5 Australia Psittacosis Treatment Market, By Mode of Purchase |
6.5.1 Overview and Analysis |
6.5.2 Australia Psittacosis Treatment Market Revenues & Volume, By Prescription, 2021- 2031F |
6.5.3 Australia Psittacosis Treatment Market Revenues & Volume, By Over the Counter, 2021- 2031F |
6.6 Australia Psittacosis Treatment Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Australia Psittacosis Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.6.3 Australia Psittacosis Treatment Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.6.4 Australia Psittacosis Treatment Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Australia Psittacosis Treatment Market Import-Export Trade Statistics |
7.1 Australia Psittacosis Treatment Market Export to Major Countries |
7.2 Australia Psittacosis Treatment Market Imports from Major Countries |
8 Australia Psittacosis Treatment Market Key Performance Indicators |
8.1 Number of reported psittacosis cases in Australia |
8.2 Percentage of healthcare professionals trained in psittacosis diagnosis and treatment |
8.3 Research and development investment in new psittacosis treatment options |
9 Australia Psittacosis Treatment Market - Opportunity Assessment |
9.1 Australia Psittacosis Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Psittacosis Treatment Market Opportunity Assessment, By Antibiotic Type, 2021 & 2031F |
9.3 Australia Psittacosis Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 Australia Psittacosis Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Australia Psittacosis Treatment Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
9.6 Australia Psittacosis Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Psittacosis Treatment Market - Competitive Landscape |
10.1 Australia Psittacosis Treatment Market Revenue Share, By Companies, 2024 |
10.2 Australia Psittacosis Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |